Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T P Miller

Showing results (51-60 of 130) with videos related to

Pageof 13
Sort By:
Cancer Treatment Reports|September 1, 1986
Extensive non-small cell lung cancer treated with mitomycin, cisplatin, and vindesine (MiPE): a Southwest Oncology Group StudyT P Miller, R B Vance, F R Ahmann, et al.
Leukemia|March 1, 1993
Deficient tumor-infiltrating T-lymphocyte response in malignant lymphoma: relationship to HLA expression and host immunocompetenceA F List, C M Spier, T P Miller, et al.
Alzheimer Disease and Associated Disorders|January 1, 1991
Cognitive decline in patients with Alzheimer disease: differences in patients with and without extrapyramidal signsT P Miller, J R Tinklenberg, J O Brooks, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
A phase II study of bisantrene in malignant lymphomas. A Southwest Oncology Group StudyT P Miller, J D Cowan, B A Neilan, et al.
Leukemia & Lymphoma|December 1, 1993
NCAM (CD56)-positive malignant lymphomaW F Kern, C M Spier, T P Miller, et al.
Cancer Treatment Reports|March 1, 1982
Extensive adenocarcinoma and large cell undifferentiated carcinoma of the lung treated with 5-FU, vindesine, and mitomycin (FEMi): a Southwest Oncology Group StudyT P Miller, J K Weick, P N Grozea, et al.
Cancer Treatment and Research|January 1, 1996
The phenomenon of multidrug resistance in non-Hodgkin's lymphomaT P Miller, E M Chase, W S Dalton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1983
Treatment of advanced breast cancer with mitomycin C combined with vinblastine or vindesineH S Garewal, R J Brooks, S E Jones, et al.
Cancer Treatment Reviews|September 1, 1980
Phase II trial of vindesine in breast cancer, lymphoma and other tumors: future directionsT P Miller, S E Jones, A B Chester, et al.
Cancer|February 1, 1988
Lennert's lymphoma. A clinicopathologic study with emphasis on phenotype and its relationship to survivalC M Spier, S M Lippman, T P Miller, et al.
Pageof 13

Showing results (51-60 of 130) with videos related to

Sort By:
Pageof 13
Cancer Treatment Reports|September 1, 1986
Extensive non-small cell lung cancer treated with mitomycin, cisplatin, and vindesine (MiPE): a Southwest Oncology Group StudyT P Miller, R B Vance, F R Ahmann, et al.
Leukemia|March 1, 1993
Deficient tumor-infiltrating T-lymphocyte response in malignant lymphoma: relationship to HLA expression and host immunocompetenceA F List, C M Spier, T P Miller, et al.
Alzheimer Disease and Associated Disorders|January 1, 1991
Cognitive decline in patients with Alzheimer disease: differences in patients with and without extrapyramidal signsT P Miller, J R Tinklenberg, J O Brooks, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
A phase II study of bisantrene in malignant lymphomas. A Southwest Oncology Group StudyT P Miller, J D Cowan, B A Neilan, et al.
Leukemia & Lymphoma|December 1, 1993
NCAM (CD56)-positive malignant lymphomaW F Kern, C M Spier, T P Miller, et al.
Cancer Treatment Reports|March 1, 1982
Extensive adenocarcinoma and large cell undifferentiated carcinoma of the lung treated with 5-FU, vindesine, and mitomycin (FEMi): a Southwest Oncology Group StudyT P Miller, J K Weick, P N Grozea, et al.
Cancer Treatment and Research|January 1, 1996
The phenomenon of multidrug resistance in non-Hodgkin's lymphomaT P Miller, E M Chase, W S Dalton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1983
Treatment of advanced breast cancer with mitomycin C combined with vinblastine or vindesineH S Garewal, R J Brooks, S E Jones, et al.
Cancer Treatment Reviews|September 1, 1980
Phase II trial of vindesine in breast cancer, lymphoma and other tumors: future directionsT P Miller, S E Jones, A B Chester, et al.
Cancer|February 1, 1988
Lennert's lymphoma. A clinicopathologic study with emphasis on phenotype and its relationship to survivalC M Spier, S M Lippman, T P Miller, et al.
Pageof 13